Liddell M, Williams J, Bayer A, Kaiser F, Owen M
Department of Psychological Medicine, University of Wales College of Medicine, Cardiff, UK.
J Med Genet. 1994 Mar;31(3):197-200. doi: 10.1136/jmg.31.3.197.
The Apo E genotype of 86 patients with Alzheimer's disease (AD) and 77 age matched controls was determined by digestion of Apo E PCR products with the restriction enzyme CfoI. The frequency of the e4 allele was significantly increased in the patient group (0.33) as compared with controls (0.12). This effect was seen in patients with a family history and in sporadic cases. The odds ratio in homozygotes for the e4 allele was 11.24 (95% confidence interval 2.45-51.50). There was no relationship between age of onset and Apo E genotype. There was no linkage disequilibrium between the apolipoprotein E locus and a TaqI polymorphism at the Apo CII locus, and no allelic association between Apo CII and AD.
采用限制性内切酶CfoI消化载脂蛋白E(Apo E)聚合酶链反应(PCR)产物,测定了86例阿尔茨海默病(AD)患者及77例年龄匹配对照者的Apo E基因型。与对照组(0.12)相比,患者组中ε4等位基因频率显著升高(0.33)。在有家族史的患者和散发病例中均观察到这种效应。ε4等位基因纯合子的优势比为11.24(95%置信区间2.45 - 51.50)。发病年龄与Apo E基因型之间无相关性。载脂蛋白E基因座与载脂蛋白CII(Apo CII)基因座的TaqI多态性之间无连锁不平衡,且Apo CII与AD之间无等位基因关联。